Non-ST Segment Elevation Myocardial Infarction Associated with IV Infusion of Immunoglobulin

Authors

  • Tamar Koleba Capital Health
  • Farzana A. Sayani University of Alberta
  • Margaret L. Ackman Capital Health

DOI:

https://doi.org/10.4212/cjhp.v58i4.320

Abstract

INTRODUCTION

IVimmunoglobulin (IVIG) is used in the treatment of a variety of disorders, including primary and secondary immunodeficiency diseases, Kawasaki disease, and idiopathic thrombocytopenia purpura.1 Although serious adverse cardiovascular reactions are rare, a recent article reviewed 28 published cases of thrombotic complications occurring in association with IVIG administration between 1986 and 2003.2 An additional 36 cases reported recently3-9 were not included in the review. This article describes 2 patients treated in the same month at the authors’ institution for non-ST segment elevation myocardial infarction possibly associated with IVIG administration. To the authors’ knowledge, case 1 represents the first reported case of a patient experiencing non-ST segment elevation myocardial infarction after each of 2 consecutive doses of IVIG.

Downloads

Download data is not yet available.

Downloads

Issue

Section

Case Report(s) / Observation(s) clinique(s)